Ambulatory surgery centers are taking on more volume, more complexity, and a greater share of procedural care than ever before. On paper, that should translate into stronger financial performance.
In practice, many facilities are working harder without seeing proportional gains.
A 2023 survey by Sage Growth Partners found that healthcare organizations lose up to 15 percent of annual revenue to inefficiencies. For a five million dollar ASC, that represents roughly seven hundred and fifty thousand dollars in lost revenue each year. That loss is rarely obvious. It does not sit in one place. It accumulates across decisions that appear routine and go unchallenged.
Most centers underperform when the full value of each case is not captured at the facility level, even when demand remains strong.
The gap between case volume and financial performance
Higher case volume often creates the impression of strong performance. Schedules are full, surgeons are productive, and throughput is consistent.
That does not always translate into margin.
Many ambulatory surgery centers operate within reimbursement structures that were set when case mix was less complex. As more advanced procedures move into outpatient settings, the facility absorbs higher costs without a corresponding adjustment in how those cases are reimbursed.
Over time, that gap becomes embedded in the business.
Where revenue is actually lost inside ambulatory surgery centers
The most consistent revenue gaps are not always visible in standard reporting. They sit within areas that are treated as fixed or are not examined closely.
Case mix is undervalued
Procedures that share the same coding can vary significantly in complexity. Differences in patient condition, surgical approach, and intraoperative requirements all affect resource utilization.
When reimbursement does not reflect those differences, higher-acuity cases begin to dilute margins instead of strengthening them.
Facility strategy lags behind surgeon strategy
Surgeons typically manage their own reimbursement with precision. Documentation, coding, and payer mix are actively controlled because the impact is immediate.
The facility side often operates differently.
This creates a disconnect where the professional component is optimized while the facility component is left to follow standard reimbursement pathways. The ASC carries the cost of delivering complex care but does not consistently capture the financial value tied to it.
Payer behavior is treated as fixed
ASC insurance strategy is often passive. In-network rates are accepted as given, and out-of-network cases are handled without a defined approach.
This limits flexibility.
Reimbursement outcomes tend to follow payer benchmarks rather than the specifics of the case, even when there is room to influence those outcomes.
Implant and supply economics are not aligned
Implant-intensive procedures introduce significant variability in cost.
When billing structure, coding, and reimbursement strategy are not aligned with that variability, the financial impact is absorbed by the facility. These gaps are rarely isolated. They tend to repeat across similar cases.
Pre-service decisions are not financially structured
Most facilities review cases before they are scheduled. That review is usually operational, focused on clinical readiness and logistics.
The financial structure behind the case is not always addressed at the same level. By the time the case reaches billing, key variables are already set. At that point, there is limited ability to influence the outcome.
Why these gaps compound over time
Individually, each of these issues may seem manageable. Together, they shape overall performance in a way that is difficult to isolate at first glance.
What begins as small misalignment at the case level turns into structural pressure on the business.
Over time, facilities start to see consistent patterns:
Margins tighten even as volume grows
Higher-acuity cases require more resources, but reimbursement often remains anchored to lower-complexity assumptions. As more of these cases enter the mix, they dilute overall performance rather than enhance it.Cash flow becomes less predictable
Variability in reimbursement increases, payment timelines stretch, and forecasting becomes less reliable. This introduces friction across staffing, scheduling, and supply planning.Reinvestment becomes more constrained
Capital that could support new equipment, expanded services, or surgeon recruitment is absorbed by underperformance at the case level. Growth begins to rely more heavily on increasing volume.A performance ceiling takes shape
The ASC continues to operate at a high clinical level, but financial outcomes plateau because the underlying structure has not been addressed.
None of this happens abruptly. It builds gradually, often without a clear point of failure.
This is why many ASCs feel pressure despite maintaining strong surgical throughput. The issue sits in how consistently clinical activity is translated into reimbursement across the full case mix.
What high-performing ambulatory surgery centers do differently
Facilities that consistently perform at a higher level approach case value more deliberately. They look beyond volume and evaluate each case in terms of its full financial profile.
That includes:
Aligning surgeon and facility perspectives on reimbursement
Evaluating whether reimbursement reflects case complexity
Understanding how payer behavior will influence the outcome
Making adjustments before the procedure takes place
This approach creates more consistency. It also reduces the reliance on post-service correction and improves how cases perform from the outset.
A more deliberate approach to facility monetization
Stronger ASC performance usually comes from getting more out of the cases already being performed, rather than relying on additional volume to close the gap.
That shift starts with how facility reimbursement is approached day to day. In many centers, it is treated as something that follows the case. In higher-performing environments, it is considered earlier, shaped alongside clinical planning, and revisited as payer dynamics come into play.
There are practical inflection points where this makes a difference. How a case is evaluated before it is scheduled. How complexity is documented and supported. How payer expectations are anticipated rather than reacted to after the claim is processed. Small changes at those points tend to carry through the entire lifecycle of the case.
Over time, this creates a different financial profile. Reimbursement begins to track more closely with the level of care being delivered, and the gap between clinical performance and financial performance narrows in a way that is consistent rather than episodic.
The Valedo perspective
At Valedo, facility monetization is treated as part of the full case lifecycle.
Each case is evaluated for where value exists and how that value can be reflected in reimbursement. That includes aligning clinical inputs with financial strategy and ensuring that decisions made before the procedure support stronger outcomes after it.
The goal is consistency. Not one-off improvements, but a repeatable approach that improves how cases perform across the board.
The revenue is already there
Most ambulatory surgery centers already have the case mix needed to perform at a higher level. The challenge is not finding new revenue. It is capturing the value that already exists within the cases being performed every day.
Facilities that take a more structured approach to case evaluation and reimbursement tend to see that shift clearly. Those that do not often continue to operate with hidden gaps that compound over time.
If your ASC is performing at a high clinical level but financial outcomes feel constrained, the gap is usually in how facility value is being captured. Valedo works with ambulatory surgery centers and surgical suites to identify where revenue is being under-realized and to implement strategies that improve performance across existing cases.
